ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is recognized as the most aggressive form of breast cancer and is defined by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [32].